SMTL ID : 8x71.1

Crystal structure of Peroxiredoxin I in complex with compound 19-064

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.58 Å

Oligo State

homo-dimer

Ligands

2 x YCC: methyl 3-[[(2~{R},4~{a}~{S},6~{a}~{R},6~{a}~{S},14~{a}~{S},14~{b}~{R})-2,4~{a},6~{a},6~{a},9,14~{a}-hexamethyl-10-oxidanyl-11-oxidanylidene-1,3,4,5,6,13,14,14~{b}-octahydropicen-2-yl]carbamoylamino]oxetane-3-carboxylate(Covalent)

YCC.1: 2 residues within 4Å: Chain A: V.172, C.173 No protein-ligand interaction detected (PLIP) YCC.2: 2 residues within 4Å: Chain B: C.173, P.174 1 PLIP interactions: 1 interactions with chain B Hydrophobic interactions: B:P.174

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, J. et al., Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient Treatment of Acute Myeloid Leukemia and Overcoming Resistance of FLT3 Inhibitors. J.Med.Chem. (2024)

Release Date

2024-06-19

Peptides

Peroxiredoxin-1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Peroxiredoxin-1

Related Entries With Identical Sequence